Ozempic Dosing Schedule: The Complete Guide to Semaglutide Titration

Your doctor prescribed Ozempic. You have the pen. And now you're trying to figure out why there are four doses printed on the box, whether you're supposed to stay at the low dose forever, and what happens if you miss a week.

This is the guide your prescriber probably didn't have time to walk you through. Not the package insert (that reads like a legal document). A plain-English explanation of how Ozempic dosing actually works, what the titration schedule is doing to your body, how to inject it correctly, and what to do when things don't go according to plan.

Last updated: April 2026. We review this article every 90 days to keep dosing information current.

---

What Is the Standard Ozempic Dosing Schedule?

The standard Ozempic dosing schedule for type 2 diabetes starts at 0.25 mg once weekly for four weeks, then increases to 0.5 mg for at least four weeks. From there, your provider can move you to 1 mg weekly if you need better glucose control. For type 2 diabetes, the maximum approved dose is 2 mg weekly (approved in 2022). For Wegovy (semaglutide for weight loss), the target dose is 2.4 mg weekly after a longer titration.

This isn't a fast ramp. It's intentionally gradual.

The reason: semaglutide works by slowing gastric emptying and activating GLP-1 receptors in your gut and brain (Novo Nordisk, 2025). Both of those effects cause nausea, vomiting, and GI distress if you start at a therapeutic dose from day one. The titration schedule is essentially your body learning to tolerate what the drug does. You're not getting full treatment benefit at 0.25 mg. That starting dose exists entirely to get your gut acclimated.

Phase	Dose	Duration	Purpose
Initiation	0.25 mg once weekly	4 weeks	Tolerability only, not therapeutic
Standard maintenance	0.5 mg once weekly	Minimum 4 weeks	First therapeutic dose
Intensification	1 mg once weekly	Minimum 4 weeks if needed	Better glucose/weight control
Maximum (T2D)	2 mg once weekly	Ongoing	Maximum approved dose for diabetes
Wegovy target	2.4 mg once weekly	After 16-week titration	Chronic weight management

This is the Novo Nordisk label-recommended schedule, confirmed by the FDA-approved prescribing information.

---

How the Titration Works — And Why It Matters

Most people understand that you start low and go up. Fewer understand why the schedule exists the way it does or what's actually happening at each step.

Semaglutide has a half-life of approximately one week, which is why it's dosed weekly. After multiple doses, it reaches steady-state plasma concentration, meaning the level in your blood stabilizes. At 0.25 mg, that steady-state is below the therapeutic window for glycemic control or meaningful appetite suppression. You're conditioning your gut receptors, not treating your diabetes.

The pharmacokinetics matter here. A randomized trial in healthy subjects demonstrated that pre-dose fasting has a significant impact on semaglutide exposure (Van Hout et al., 2023). Subjects who fasted overnight before the oral version showed substantially higher drug concentrations than those who fasted for shorter periods. For injectable semaglutide, the route bypasses this issue. Subcutaneous absorption is more predictable than oral. But the point stands: how you administer this drug changes how your body processes it.

When you move from 0.5 mg to 1 mg, you're roughly doubling the circulating drug level at steady state. That's why GI side effects often spike at dose escalation points. You've done the conditioning work at the lower dose, but the higher concentration still asks more of your system. This is also why providers sometimes extend the titration period rather than push through on schedule.

A Phase 3 trial specifically investigated slow titration (NCT04447859, Tel-Aviv Sourasky Medical Center, n=100), comparing 16-week flexible escalation against the standard 8-week schedule, to quantify the effect on GI adverse events. The concept tracks: slower titration means lower peak concentrations during escalation, which means your gut adapts before the drug level climbs too high.

The STEP 2 trial showed 9.6% mean body weight reduction versus 3.4% with placebo after 68 weeks of semaglutide 2.4 mg in patients with type 2 diabetes and overweight or obesity (Davies et al., 2021). That's roughly 18-20 pounds for someone starting at 200 lbs. But those results required reaching and maintaining the therapeutic dose. Another reason the titration schedule isn't optional.

---

Wegovy vs Ozempic: Different Doses, Different Schedules

Ozempic and Wegovy contain the same drug. The difference is the indication and the approved maximum dose.

Ozempic (semaglutide injection) is FDA-approved for type 2 diabetes, with a maximum dose of 2 mg weekly (Villela & Correa, 2021). Wegovy (semaglutide injection) is FDA-approved for chronic weight management in adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition. Wegovy's target dose is 2.4 mg weekly, reached after a 16-week titration.

The Wegovy schedule is longer because the doses are higher and the indication requires more aggressive titration to manage GI effects at 2.4 mg:

Week	Wegovy Dose
Weeks 1-4	0.25 mg weekly
Weeks 5-8	0.5 mg weekly
Weeks 9-12	1 mg weekly
Weeks 13-16	1.7 mg weekly
Week 17 onward	2.4 mg weekly (maintenance)

If a patient can't tolerate the move to the next dose level, the label allows staying at the current dose for an additional four weeks before trying again.

The 2.4 mg dose in Wegovy accounts for much of the clinical trial data you see cited in weight loss contexts. The STEP 1 trial (Wilding et al., 2021) showed a mean body weight reduction of 14.9% over 68 weeks (n=1,961). That's about 30 pounds for someone starting at 200 lbs. That's the 2.4 mg Wegovy dose. The Ozempic label doses (0.5 mg to 2 mg) produce meaningful weight loss too, but the magnitude is generally lower.

If you're on Ozempic for diabetes and also losing weight, your provider may be using the diabetes-approved doses. If weight loss is the primary goal and you're eligible, they may transition you to Wegovy or a compounded semaglutide protocol to reach higher doses.

You can also compare how semaglutide stacks up against other GLP-1 options in our GLP-1 medications compared guide.

---

How to Inject Ozempic Correctly

The injection technique matters more than most people realize. Done wrong, you're losing drug to the wrong tissue layer or creating injection-site reactions that make you dread the weekly shot.

Ozempic is injected subcutaneously, into the fat layer just beneath the skin, not into muscle. The three approved sites are the abdomen (at least 2 inches from the navel), the front of the thigh, and the upper arm. All three work equally well for absorption.

A head-to-head study comparing injection delivery devices found that formulation differences between single-dose and multi-dose pens affected injection-site discomfort (Snitker et al., 2022). The multi-dose pen (standard Ozempic) contains a preservative (phenol) that actually reduces pain compared to some single-dose formulations. Point being: the pen you're using was designed with injection experience in mind. Don't try to transfer it to a syringe to "microdose" unless your provider has specifically directed you to do so.

Step-by-step injection protocol:

1. Pick an injection site and clean it. Wipe with an alcohol pad and let it dry completely before injecting. Wet alcohol under the skin burns.

2. Attach a new needle. Use a fresh pen needle every time. Reusing needles dulls the tip, increases pain, and risks contamination.

3. Prime the pen before first use. The instructions say to turn the dose selector to the flow check symbol and press until a drop appears at the needle tip. Skip this and your first dose may be air.

4. Dial the correct dose. Confirm the number in the window before injecting. This is where mistakes happen, including the common Reddit scenario of accidentally dialing to 1 mg when you meant 0.5 mg.

5. Pinch a fold of skin and insert the needle. For most sites, a 90-degree angle is correct. If you're very lean, 45 degrees prevents hitting muscle. Insert the full needle length.

6. Press and hold the button for at least 6 seconds. Releasing too early means incomplete delivery. The Ozempic pen is not a fast-click device. Count it out.

7. Remove the needle, recap it, and dispose in a sharps container. Don't leave used needles uncapped. Sharps injuries from pen needles happen to family members in the trash.

8. Rotate injection sites. Never inject the same exact spot two weeks in a row. Rotating within a site and between sites prevents lipohypertrophy (the lumpy scar tissue that forms from repeated injections in the same spot, which actually reduces drug absorption).

The rotation rule is more important than most people follow. If you have a preferred stomach spot because it's easy, you're probably already building a small lipodystrophy there. Mix it up: left lower abdomen this week, right thigh next week, upper arm the week after.

---

Slow-Titration Protocols: When the Standard Schedule Is Too Fast

For some people, the standard 4-week titration intervals are too aggressive. The nausea at 0.5 mg is severe enough that they stop taking the medication entirely. This is a fixable problem, but you have to know it's an option.

The slow-titration approach extends each dose level longer than the label minimum. Instead of moving from 0.25 mg to 0.5 mg after four weeks, you stay at 0.25 mg for 8 weeks. Or you move up but stay at 0.5 mg for 8-12 weeks before going to 1 mg. Some providers use intermediate doses if compounded semaglutide is part of the protocol.

A real-world study across 626 semaglutide users found that only 20.3% of users followed standard dose escalation protocols (Alqaaneh et al., 2025). The plurality were adjusting timing on their own based on tolerance. That's not ideal, but it reflects the reality that the label schedule doesn't work for a significant portion of patients without modification.

The Phase 3 flexible titration trial (NCT04447859) was designed specifically to test whether an extended ramp reduces GI adverse events. If you're struggling with nausea or vomiting at dose escalation, ask your provider about extending your current dose before going up. The evidence supports it.

What you want to avoid is abandoning titration entirely when you hit side effects. A 2025 patient review analysis found that GI side effects were the most common reason patients discontinued, often before reaching therapeutic doses (Armanious et al., 2025). The medication can't work if you stop before getting there.

Practical signals that you might need slower titration:

• Nausea lasting more than 3-4 days after each dose
• Vomiting on more than one occasion post-dose
• Inability to eat normally 2+ days after injection
• More than 10% drop in food intake causing fatigue or weakness

None of these mean you can't take semaglutide. They mean your dose escalation schedule needs adjustment. That's a conversation to have with your provider, not a reason to quit the medication.

---

Drug Interactions: What to Tell Your Prescriber

Semaglutide's drug interactions are real and can be dangerous in specific contexts. If you're on any of the following, your provider needs to know before adjusting your Ozempic dose.

Insulin. Combining semaglutide with insulin increases hypoglycemia risk (Candido et al., 2024). As semaglutide improves insulin sensitivity and reduces appetite, the same insulin dose that was appropriate before may drive blood sugar too low. Your provider should review your insulin regimen when starting or increasing semaglutide. Insulin dose reductions are common and necessary.

Sulfonylureas (glipizide, glimepiride, glyburide). These drugs stimulate insulin secretion regardless of blood glucose level. Add semaglutide's glucose-lowering effect on top of that and hypoglycemia risk climbs significantly. Many providers reduce or eliminate sulfonylureas when adding semaglutide to a regimen.

Oral medications with narrow therapeutic windows. Semaglutide slows gastric emptying, which changes how quickly other oral drugs are absorbed. For medications where timing and peak blood levels matter (anticoagulants, certain antibiotics, thyroid medications), this can affect efficacy. There's no blanket contraindication, but your other prescribers should know you're on semaglutide.

Alcohol. Not a formal drug interaction, but relevant. Alcohol lowers blood sugar independently. If you're also on insulin or a sulfonylurea alongside semaglutide, alcohol significantly amplifies hypoglycemia risk. Even without those combinations, heavy alcohol use while on semaglutide increases pancreatitis risk, which is already a listed warning on the label.

A 2025 systematic review specifically flagged cardiovascular and gastrointestinal complications as the primary concern with unsupervised semaglutide use, including hypoglycemia risk in patients combining it with other antidiabetic agents without proper dose adjustments (Pezzi et al., 2025).

---

Contraindications: Who Should Not Take Ozempic

Ozempic carries an FDA black-box warning (the most serious type) for thyroid C-cell tumor risk. In rodent studies, semaglutide caused dose-dependent thyroid C-cell tumors at clinically relevant exposures. Whether this translates to humans is unknown. The FDA label states it clearly: RISK OF THYROID C-CELL TUMORS.

Because of this, Ozempic is contraindicated in patients with:

• A personal history of medullary thyroid carcinoma (MTC)
• A family history of MTC
• Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

These are hard contraindications. If any apply to you, semaglutide is not appropriate regardless of how well it might work for your diabetes or weight.

Other contraindications and warnings from the FDA label:

Pancreatitis. Acute pancreatitis has been reported in patients taking GLP-1 receptor agonists. A case report documented acute pancreatitis following transition from semaglutide to tirzepatide (Mando et al., 2024), with lipase at 847 U/L and worsening course requiring antibiotics. Switching between GLP-1 agents without proper titration may increase risk. Patients with a history of pancreatitis should discuss the benefit-risk profile carefully with their provider before starting.

Diabetic retinopathy. Ozempic labeling includes a warning about worsening diabetic retinopathy in patients with pre-existing retinopathy, particularly during rapid glucose reduction. If you have diabetic eye disease, your provider needs to monitor this.

Acute kidney injury. Severe vomiting and diarrhea from GI side effects can cause dehydration and kidney injury. The FDA label was updated in October 2025 to strengthen this warning.

Ischemic optic neuropathy (ION). A 2026 analysis of FDA Adverse Event Reporting System data found that Wegovy (2.4 mg) showed a stronger signal for ION than Ozempic (Lakhani et al., 2026) (reporting odds ratio 74.89 vs 18.81). Men had higher odds than women. This is a rare but vision-threatening complication that warrants monitoring, particularly at higher doses.

Pregnancy. Semaglutide should be discontinued at least 2 months before a planned pregnancy. Animal studies show fetal harm. If you're on Ozempic and planning to conceive, your provider needs to manage the transition well in advance.

None of these contraindications are reasons to avoid understanding the medication. They're reasons to have a complete conversation with your provider before starting and to report any unusual symptoms: changes in vision, severe abdominal pain, or symptoms of thyroid abnormalities (neck mass, difficulty swallowing, persistent hoarseness).

For a deeper look at how semaglutide side effects develop over time, see our Ozempic side effects guide.

---

What to Do If You Miss a Dose

Missing an Ozempic dose is common and manageable, as long as you follow the timing rules. The FDA label is clear on this.

If you miss a dose and it has been 5 days or fewer since the scheduled injection: Take the missed dose as soon as you remember. Then return to your regular weekly schedule.

If more than 5 days have passed since the missed dose: Skip it entirely. Do not take the missed dose. Wait and inject your next scheduled dose on the normal day.

Never double-dose. Taking two doses in a week to compensate for a miss can cause significant GI toxicity and hypoglycemia (if you're on insulin or a sulfonylurea). The half-life of semaglutide means doubling up creates a temporary overdose situation.

The 5-day rule makes sense when you understand the drug's pharmacokinetics. Semaglutide has a one-week half-life. If you're more than 5 days past your missed dose, you're within 2 days of when the next dose would be due anyway. Taking the missed dose now would essentially double-dose: elevated plasma levels plus a fresh dose 2 days later.

A note about pen dosing errors: The Reddit Ozempic community has a recurring thread about accidentally dialing the Ozempic pen to the wrong dose. The 1 mg pen has specific click-stops that don't align the same way the 0.5 mg pen does. If you accidentally set your pen to a higher dose than intended and haven't injected, do not inject. You cannot dial down once set. Contact your provider or pharmacy for guidance. If you accidentally inject a higher dose than intended and experience severe nausea, vomiting, or dizziness, call your provider. Severe hypoglycemia from a single accidental higher dose of semaglutide alone (without insulin/sulfonylurea) is uncommon but possible.

Practical ways to avoid missing doses:

• Set a weekly phone alarm for your injection day and time
• Link the injection to a consistent activity (Sunday morning after coffee, for example)
• Keep the pen visible, not buried in the back of the refrigerator

---

Ozempic Plateau: What Happens When It Stops Working

The question from Reddit that comes up constantly: "I've been on 1 mg for 5 months and the scale stopped moving. What do I do?"

There are a few things to work through before assuming the medication has stopped working.

Dose adequacy. At 1 mg, you're at the middle of the Ozempic dosing range. The 2 mg dose was approved precisely because some patients need higher exposure for adequate effect. If you're on 1 mg and have plateaued, a dose increase is the first reasonable step, assuming you've tolerated titration to this point.

The dose isn't the only variable. A 2025 real-world analysis found that among patients who lost weight on semaglutide, reported mean weight loss exceeded 5% at 8-12 weeks across most subgroups (Alqaaneh et al., 2025). Patients who plateaued early often had inconsistent dosing or hadn't yet reached therapeutic doses. But some patients on consistent therapeutic doses do plateau. In those cases, metabolic adaptation (the body adjusting caloric expenditure downward in response to weight loss) plays a significant role.

Frequency adjustment. Some patients on community forums have tried shortening the injection interval (every 5-6 days instead of 7) when they can't increase dose due to regional availability. This is off-label and not recommended by the label, but the pharmacokinetic rationale exists. Semaglutide at every-5-day dosing maintains higher steady-state levels. This should only be done under physician supervision.

Switching medications. If semaglutide at maximum tolerated dose isn't producing adequate results, tirzepatide (Mounjaro/Zepbound) adds a second receptor pathway (GIP in addition to GLP-1) and generally produces greater weight loss in head-to-head comparisons. See our retatrutide overview for next-generation options that add a third receptor.

The bottom line on plateaus: don't adjust frequency or dose on your own. Call your provider. If your provider isn't responsive, that's a problem with the provider, not the medication.

---

The Cost Problem — and How People Are Managing It

Cost is the number one topic in the semaglutide Reddit communities. And it's a legitimate concern.

List price: Ozempic retails at approximately $900-$1,000 per month without insurance. Wegovy is similar. These are not manageable costs for most people paying out-of-pocket.

Insurance coverage: Coverage varies enormously. Ozempic for type 2 diabetes is more commonly covered than Wegovy for weight loss, and many plans specifically exclude the weight-loss indication. Some employers have recently added GLP-1 coverage for obesity; most haven't. The semaglutide subreddit FAQ notes that coverage is "a combination of your insurer and your employer." There's no universal answer.

Manufacturer savings programs: Novo Nordisk offers savings cards that can reduce the cost significantly for eligible patients. Ozempic's savings program is at ozempic.com/savings — the terms change periodically, so check for the current offer. As of 2025, some commercially insured patients could access Ozempic for as low as $25/month under the savings card program (income and insurance eligibility restrictions apply).

Compounded semaglutide: During the FDA-declared shortage period (which ran through much of 2023-2024), compounding pharmacies legally produced semaglutide. The FDA declared the shortage resolved in 2025, which significantly restricted legal compounding. If a telehealth company is offering "compounded semaglutide" post-shortage, verify the regulatory status with your provider. The FDA has issued warning letters to some compounders.

What it costs at HEXIS: Our telehealth protocols start with a full lab panel (metabolic panel, HbA1c, lipids, and relevant hormones) before any prescription is written. The consultation is separate from the medication cost, and we can help you navigate insurance options and manufacturer programs during that visit. Contact us for current pricing, as GLP-1 access and pricing continue to shift.

---

Frequently Asked Questions About Ozempic Dosing

What's a typical Ozempic dosing schedule from the start?

The standard schedule starts at 0.25 mg once weekly for 4 weeks, then 0.5 mg for at least 4 weeks. From there, providers can increase to 1 mg or 2 mg based on glucose control and tolerance. Most patients reach a stable maintenance dose between 0.5 mg and 1 mg, though some need 2 mg for adequate control.

What do I do if I miss an Ozempic dose?

If you miss a dose and 5 or fewer days have passed, take it immediately and resume your regular schedule. If more than 5 days have passed, skip the missed dose entirely and take your next scheduled dose on the normal day. Never take two doses in one week to make up for a missed injection.

Do higher Ozempic doses cause more side effects?

Generally, yes. But most side effects occur during the titration period, not at stable maintenance. GI effects (nausea, vomiting, diarrhea) are most common in the first few weeks after a dose increase and typically improve over 4-8 weeks as your body adjusts. Some patients experience minimal side effects at any dose; others struggle at every escalation. Slow titration reduces but doesn't eliminate side effects at higher doses.

What happens if I plateau on 1 mg Ozempic?

A plateau on 1 mg warrants a conversation with your provider before taking any action on your own. Options include increasing to 2 mg (the maximum Ozempic dose for diabetes), transitioning to Wegovy if weight management is the goal, or evaluating whether a different GLP-1 or combination therapy would be more effective. Adjusting injection frequency without medical guidance is not recommended.

How long do I stay on each Ozempic dose before going up?

The minimum at each dose level is 4 weeks, per the FDA label. Many providers extend this to 6-8 weeks based on individual tolerance and glucose response. There's no maximum time to stay at a given dose. If you're at 0.5 mg and it's working well with minimal side effects, there's no clinical requirement to move higher unless glucose control is inadequate.

---

Starting Ozempic Through HEXIS Health

Semaglutide protocols need to be built around your specific metabolic picture. Your starting HbA1c, fasting glucose, kidney function, and other concurrent medications all affect how we approach dosing and monitoring.

At HEXIS, your ozempic dosing protocol begins with labs, not a questionnaire. Your provider reviews your full metabolic panel, understands what other medications you're on, and discusses the titration schedule before the first injection. Monitoring continues through your protocol, because a drug this powerful needs ongoing oversight, not a one-time prescription refill.

If you've been prescribed Ozempic by a provider who hasn't reviewed your bloodwork, hasn't discussed the titration schedule with you, or isn't accessible when you have dosing questions, that's a gap worth addressing. The medication works, but not as well, and not as safely, without proper supervision.

Schedule a consultation with a HEXIS provider to discuss whether semaglutide is right for your goals and to build a protocol around your actual numbers.

You may also want to review our metformin for weight loss guide if you're evaluating combination approaches, or how to reverse insulin resistance to understand the metabolic context that makes GLP-1 medications work.

---